Cargando…
Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas
BACKGROUND: Extranodal T/NK cell lymphomas possess distinctive clinico-pathological characteristics: they are angiocentric, exhibit extensive necrosis. Prognosis is poor in the short term. The objective is to explore the expression of different MMPs in the cells and stroma which are around of the bl...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582239/ https://www.ncbi.nlm.nih.gov/pubmed/18954439 http://dx.doi.org/10.1186/1477-7819-6-114 |
_version_ | 1782160660704002048 |
---|---|
author | Meneses-García, Abelardo Betancourt, Alejandro Mohar Abarca, Jorge Herrera Montes, Adriana Becerril Roa, Lourdes Suarez Ruíz-Godoy, Luz |
author_facet | Meneses-García, Abelardo Betancourt, Alejandro Mohar Abarca, Jorge Herrera Montes, Adriana Becerril Roa, Lourdes Suarez Ruíz-Godoy, Luz |
author_sort | Meneses-García, Abelardo |
collection | PubMed |
description | BACKGROUND: Extranodal T/NK cell lymphomas possess distinctive clinico-pathological characteristics: they are angiocentric, exhibit extensive necrosis. Prognosis is poor in the short term. The objective is to explore the expression of different MMPs in the cells and stroma which are around of the blood vessels damaged and their correlation with clinico-pathological parameters. PATIENTS AND METHODS: Twenty cases of this type of lymphomas were studied and collected patient clinical data. The expressions of MMP-1, 2, 3, 9, 11, 13 and TIMP-1, 2 were studied by immunohistochemistry. Ultrastructural studies were performed in two cases. Statistical analysis was done with Fisher's exact test, Chi(2 )test. RESULTS: Of the 20 patients, 13 were men with median age of 43 years. In 13 patients the primary tumor was localized in the nasal cavity. Treatment was combined chemotherapy and radiotherapy in 60%. The 55% advanced clinical stages, 70% died from the disease. There were neoplastic cell and peritumoral fibroblasts positivity to MMP-1 and MMP-11 in most of the cases. The MMPs-2, 3 and 9 were expressed in neoplastic cell between 30 to 65%of the cases. TIMP-1 was presented mainly in the epithelium and TIMP-2 was poor expressed of the all cases. CONCLUSION: There were no statistical significance between the different enzymes used and the clinical parameters, besides status and survival of the patients. It is necessary to study more enzymes and focus them to quantify and determine their activity, in order to have a better correlation with histological features in this type of neoplasm. |
format | Text |
id | pubmed-2582239 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-25822392008-11-12 Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas Meneses-García, Abelardo Betancourt, Alejandro Mohar Abarca, Jorge Herrera Montes, Adriana Becerril Roa, Lourdes Suarez Ruíz-Godoy, Luz World J Surg Oncol Research BACKGROUND: Extranodal T/NK cell lymphomas possess distinctive clinico-pathological characteristics: they are angiocentric, exhibit extensive necrosis. Prognosis is poor in the short term. The objective is to explore the expression of different MMPs in the cells and stroma which are around of the blood vessels damaged and their correlation with clinico-pathological parameters. PATIENTS AND METHODS: Twenty cases of this type of lymphomas were studied and collected patient clinical data. The expressions of MMP-1, 2, 3, 9, 11, 13 and TIMP-1, 2 were studied by immunohistochemistry. Ultrastructural studies were performed in two cases. Statistical analysis was done with Fisher's exact test, Chi(2 )test. RESULTS: Of the 20 patients, 13 were men with median age of 43 years. In 13 patients the primary tumor was localized in the nasal cavity. Treatment was combined chemotherapy and radiotherapy in 60%. The 55% advanced clinical stages, 70% died from the disease. There were neoplastic cell and peritumoral fibroblasts positivity to MMP-1 and MMP-11 in most of the cases. The MMPs-2, 3 and 9 were expressed in neoplastic cell between 30 to 65%of the cases. TIMP-1 was presented mainly in the epithelium and TIMP-2 was poor expressed of the all cases. CONCLUSION: There were no statistical significance between the different enzymes used and the clinical parameters, besides status and survival of the patients. It is necessary to study more enzymes and focus them to quantify and determine their activity, in order to have a better correlation with histological features in this type of neoplasm. BioMed Central 2008-10-27 /pmc/articles/PMC2582239/ /pubmed/18954439 http://dx.doi.org/10.1186/1477-7819-6-114 Text en Copyright © 2008 Meneses-García et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Meneses-García, Abelardo Betancourt, Alejandro Mohar Abarca, Jorge Herrera Montes, Adriana Becerril Roa, Lourdes Suarez Ruíz-Godoy, Luz Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas |
title | Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas |
title_full | Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas |
title_fullStr | Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas |
title_full_unstemmed | Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas |
title_short | Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas |
title_sort | expression of the metalloproteases mmp-1, mmp-2, mmp-3, mmp-9, mmp-11, timp-1 and timp-2 in angiocentric midfacial lymphomas |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582239/ https://www.ncbi.nlm.nih.gov/pubmed/18954439 http://dx.doi.org/10.1186/1477-7819-6-114 |
work_keys_str_mv | AT menesesgarciaabelardo expressionofthemetalloproteasesmmp1mmp2mmp3mmp9mmp11timp1andtimp2inangiocentricmidfaciallymphomas AT betancourtalejandromohar expressionofthemetalloproteasesmmp1mmp2mmp3mmp9mmp11timp1andtimp2inangiocentricmidfaciallymphomas AT abarcajorgeherrera expressionofthemetalloproteasesmmp1mmp2mmp3mmp9mmp11timp1andtimp2inangiocentricmidfaciallymphomas AT montesadrianabecerril expressionofthemetalloproteasesmmp1mmp2mmp3mmp9mmp11timp1andtimp2inangiocentricmidfaciallymphomas AT roalourdessuarez expressionofthemetalloproteasesmmp1mmp2mmp3mmp9mmp11timp1andtimp2inangiocentricmidfaciallymphomas AT ruizgodoyluz expressionofthemetalloproteasesmmp1mmp2mmp3mmp9mmp11timp1andtimp2inangiocentricmidfaciallymphomas |